Estimated read time: 2-3 minutes
This archived news story is available only for your personal, non-commercial use. Information in the story may be outdated or superseded by additional information. Reading or replaying the story in its archived form does not constitute a republication of the story.
WESTBOROUGH, Mass.--(BUSINESS WIRE)--Mar 6, 2014--IBC Life Sciences, the organizer of market leading events in drug discovery and biologics development, today announced that a high profile group of companies will unveil their new products at Biopharmaceutical Development & Production Week Conference (BDP Week). Held from March 24-27 at the Hilton Bayfront Hotel in San Diego, BDP Week is the annual event where attendees learn about and evaluate the latest bioprocessing methods, technologies and services required for developing the next-generation of biologic drugs.
This year’s BDP Week will attract more than 800 delegates from around the world and feature six keynotes presentations, 175+ Speakers, 50+ posters and 65+ exhibitors. For the entire BDP Week program, visit: http://www.ibclifesciences.com/BDPWeek.
Significant commercial opportunities exist for biopharmaceutical firms developing new and improved biologics including mAbs, vaccines, ADCs, recombinant proteins, bispecifics, enzymes, biosimilars and cell/gene therapy. For example, according to Datamonitor biologics will generate 82% of total pharma growth through 2016.
A leading group of the companies who are in the forefront enabling the development of new biological products are launching their new products at BDP Week, include applikon, Asahi Kasei, BD Biosciences, Bio-Rad, Catalent, Charles River, Cook Pharmica, eurofins, Fuji Diosynth, Life technologies, Grace, Lonza, Natrix, Parker, Sandoz, Sartorius Stedim, Spectrum Labs and Tosoh. For more detail about these new product presentation, visit: http://www.ibclifesciences.com/BDPWeek/newproductlaunch.xml.
"BDP Week plays an important role in advancing and demonstrating our leadership as an innovator in media supplementation," said Robert M Hallenbeck, Vice President – BD Biosciences - Advanced Bioprocessing. "At BDP Week 2014, BD is launching our new line of chemically defined media supplements, BD Resurge to the industry. BD Resurge will enhance recombinant protein production of CHO cells while maintaining product quality."
About IBC Life Sciences IBC Life Sciences leads the market by providing quality, expert-led conferences and courses for pharmaceutical, biotechnology, academics and government organizations. Conference and course topics cover drug discovery, as well as all phases of bioprocess development. www.IBCLifeSciences.com
IBC Life Sciences hosts the annual BioProcess International™ (BPI) Conference and Exhibition. The BioProcess International Conference & Exhibition is where the biologics value chain meets to do business. Each year BPI attracts over 1500 biologics industry leaders for four days of power networking and learning. No other industry event delivers the high-level connections and insight needed to accelerate your business. Use this preeminent industry platform to showcase your company, products and thought leadership. To get involved, visit www.IBCLifeSciences.com/BPI.
Photos/Multimedia Gallery Available:http://www.businesswire.com/multimedia/home/20140306005091/en/
CONTACT: IBC Life Sciences
Ellen Cabral, 508-614-1213
KEYWORD: UNITED STATES NORTH AMERICA CALIFORNIA MASSACHUSETTS
INDUSTRY KEYWORD: HEALTH BIOTECHNOLOGY GENETICS MEDICAL DEVICES PHARMACEUTICAL RESEARCH MEDICAL SUPPLIES SCIENCE GENERAL HEALTH
SOURCE: IBC Life Sciences
Copyright Business Wire 2014
PUB: 03/06/2014 08:00 AM/DISC: 03/06/2014 08:00 AM
Copyright © The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.